Boston Scientific Features New Everolimus-Eluting Coronary Stent

 

September 10, 2008

The FDA recently cleared Boston Scientific Corp.’s PROMUS Everolimus-Eluting Coronary Stent System.

Boston Scientific said the PROMUS Stent is highly deliverable, made from cobalt chromium, which allows for thinner struts without sacrificing strength or visibility.

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.